US Patent Issued to The Johns Hopkins University, THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services on Jan. 28 for "Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)" (Maryland Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,093, issued on Jan. 28, was assigned to The Johns Hopkins University (Baltimore) and THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)" was invented by Ravit Boger (Baltimore), Marc Ferrer (Potomac, Md.), Juan Marugan (Gaithersburg, Md.), Andres Dulcey Garcia (Gaithersburg, Md.), Noel Terrence Southall (Potomac, Md.) and Xin Hu (Frederick, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of virology. More specifically, the present invention provides methods and composi...